| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 0.005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |